DRKS00024214暂停不适用
Analysis of the effect of SARS-CoV-2 vaccination in patients with chronic inflammatory diseases - SAVE-CID
KSH Kiel/1. medizinische Klinik/Rheumatologie0 个研究点目标入组 100 人开始时间: 2021年2月17日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •a SARS-CoV-2 vaccination is planned. In addition, one of the following diseases: standard criteria (ACR/EULAR) for diagnosed Rheumatoid arthritis, spondyloarthorpathy, vasculitis or collagenosis. Gastroenterological diagnosed chronic inflammatory bowel disease (Morbus Crohn or Colitis Ulcerosa), Dermatologically confirmed Psoriasis.
- •For the control group, the mentioned diseases are exclusion criteria.
- •In addition, written informed consent is needed.
排除标准
- •maligne disease, other autoimmune diseases (with immunosuppressive therapy), Infections (e.g. HIV, Hep C, Hep B) Age under 18 years, lacking capacity to consent.
研究者
相似试验
招募中
2 期
The evaluation of the effect of COVID-19 vaccination on calprotectin levels in IBD patientsIRCT20210113050024N3Esfahan University of Medical Sciences30
招募中
4 期
Efficacy of vaccine responses against SARS-Cov-2 in patients with giant cell arteritis and polymyalgia rheumatica (GPSVAC)NL-OMON51139niversitair Medisch Centrum Groningen80
招募中
2 期
Evaluation of the Pastocovac (COVID-19 vaccine) efficacy following autologous stem cell transplantatioCondition 1: Autologous stem cell transplantation. Condition 2: SARS-CoV-2 vaccine efficacy.SARS-CoV-2 vaccine effectivenessIRCT20140818018842N23Tehran University of Medical Sciences124
已完成
4 期
ong term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease stage G4-G5, on dialysis or after kidney transplantation. A prospective observational cohort study by the REnal patients COVID-19 VACcination (RECOVAC) consortiumniertransplantatie, nieraandoeningen zowel in- als exclusief nefropathieëndialysiskidney insufficiencykidney transplantatie1004743810038430NL-OMON50845niversitair Medisch Centrum Groningen12,000
进行中（未招募）
1 期
ong term efficacy and safety of COVID-19 vaccination in patients with a kidney diseaseCOVID-19 is associated with increased morbidity and mortality in kidneytransplant recipients (KTR) and patients with chronic kidneydisease(CKD). Therefore, potential efficacious SARS-CoV-2 vaccination would beof great clinical importance in these patients.However, SARS-CoV-2vaccination studies have excluded KTR and patients with CKD so-far and it is unknown how long a possible antibody response will endure.This will be the subject of this trial.MedDRA version: 23.1Level: LLTClassification code 10084401Term: COVID-19 respiratory infectionSystem Organ Class: 100000004862MedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 23.1Level: LLTClassification code 10084465Term: COVID-19 vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 23.1Level: LLTClassification code 10084508Term: COVID-19 antibody testSystem Organ Class: 100000004848MedDRA version: 23.0Level: LLTClassification code 10084270Term: SARS-CoV-2 acute respiratory diseaseSystem Organ Class: 100000004862MedDRA version: 23.0Level: LLTClassification code 10084272Term: SARS-CoV-2 infectionSystem Organ Class: 100000004862MedDRA version: 23.0Level: LLTClassification code 10084462Term: SARS-CoV-2 vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 23.0Level: LLTClassification code 10084463Term: SARS-CoV-2 immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: PTClassification code 10023439Term: Kidney transplant rejectionSystem Organ Class: 10021428 - Immune system disordersMedDRA version: 20.0Level: LLTClassification code 10023438Term: Kidney transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: PTClassification code 10061105Term: DialysEUCTR2021-001520-18-NLRECOVAC consortium24,300